ECNP New Frontiers meeting

The ECNP New Frontiers Meeting was launched to tackle the challenges in translational neuroscience that are impeding the development of new treatments and discouraging investment in the field.

ECNP is in a unique position to provide a central, independent, precompetitive platform for the exchange of insights and ideas across the spectrum of CNS research and development.

The New Frontiers Meeting is designed to bring academics, industry leaders and regulators together to explore exciting new areas of emerging science and map out promising new research horizons.

The meeting has become an essential platform for focused, high-level exchange between Europe’s leading specialists in the science of CNS treatments at the intersection of research science and new treatment development.

In 2017 the meeting was given the overarching name of the ECNP New Frontiers Meeting, with a dedicated interdisciplinary programme committee.

The meeting is held over two intense days every year in mid-March in Nice, France, in conjunction with the ECNP Workshop. Topics to date have covered biomarkers in psychiatry, the neuroscience of psychological treatments and mechanism-based CNS targets in psychiatric drug development.

Research in new treatments for brain disorders is under threat. There is a pressing need for all interested parties to work together to minimise the damage that this will cause to the care of patients. This ECNP initiative is the beginning of a process that we hope will begin to rectify the current situation and build a strong foundation for the future.”

D. Nutt and G. Goodwin, ‘ECNP Summit on the Future of CNS drug research in Europe 2011’*
*European Neuropsychopharmacology (2011) 21, 495-499.